Jakemans Throat and Chest Anise

Description

JAKEMANS is a throat and chest lozenge that features an anise flavor complemented by other natural flavors. Each lozenge contains menthol, which serves as a cough suppressant, and provides oral anesthetic properties. Manufactured in Boston, England, JAKEMANS has been produced for over 100 years, utilizing the finest natural ingredients. The product is available in a package containing 24 lozenges.

Uses and Indications

This drug is indicated for use as a menthol cough suppressant and as an oral anesthetic.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 2 years and older are instructed to dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional.

For children under 2 years of age, it is recommended to consult a doctor before administration.

Contraindications

Use is contraindicated in patients with a persistent or chronic cough associated with smoking, asthma, or emphysema, due to the potential for exacerbation of these conditions. Additionally, the product should not be used in individuals experiencing a cough accompanied by excessive phlegm (mucus), as this may indicate an underlying condition that requires different management.

Warnings and Precautions

Patients should be advised of the potential for a sore throat as a warning sign. In cases where the sore throat is severe, persists for more than two days, or is accompanied by additional symptoms such as fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

Healthcare providers should exercise caution and recommend that patients seek medical advice prior to use if they have a persistent or chronic cough, particularly in cases associated with smoking, asthma, or emphysema. Additionally, patients experiencing a cough that is accompanied by excessive phlegm (mucus) should also consult their physician before initiating treatment.

Currently, there are no specific laboratory tests or emergency medical help instructions provided in the insert. It is essential for healthcare professionals to remain vigilant and monitor patients for any concerning symptoms that may arise during treatment.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. A notable warning includes the potential for a sore throat. If a sore throat is severe, persists for more than two days, or is accompanied or followed by symptoms such as fever, headache, rash, swelling, nausea, or vomiting, patients are advised to consult a doctor promptly.

Additionally, it is important for patients to seek medical advice before using this medication if they have a persistent or chronic cough, particularly as may occur with smoking, asthma, or emphysema. Patients with a cough that occurs with excessive phlegm (mucus) should also consult a healthcare professional prior to use.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Jakemans Throat and Chest Anise (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the lozenge should be dissolved slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a healthcare provider.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and treatment protocols tailored to the substance involved. Continuous monitoring and supportive measures should be implemented until the patient is stabilized and any potential complications are addressed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious adverse events have been reported voluntarily or through surveillance programs. For reporting such events, individuals are advised to contact the designated helpline at 1-866-205-1185.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important for patients to consult with their doctor prior to use if they have a persistent or chronic cough, particularly if it is associated with smoking, asthma, or emphysema. Additionally, patients should be instructed to seek medical advice if their cough is accompanied by excessive phlegm (mucus). This guidance is essential to ensure safe and effective use of the medication.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to avoid any potential safety risks.

Additional Clinical Information

The medication is administered orally, with adults and children aged 2 years and older instructed to dissolve the lozenge slowly in the mouth. Dosing may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is recommended prior to use.

Clinicians are advised to report any serious adverse events associated with the medication by calling 1-866-205-1185. No additional information is available regarding laboratory tests, abuse potential, or patient counseling.

Drug Information (PDF)

This file contains official product information for Jakemans Throat and Chest Anise, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)